Research Article
Measures of Rheumatoid Arthritis Disease Activity in Australian Clinical Practice
Table 1
Patient demographics and treatments.
| | | All patients () | Biologic patients () | Nonbiologic patients () |
| | Mean age, years (range) | 58.6 (15–85) | 55.4 (15–82) | 60.2 (23–85) | | Female (%) | 70 | 75 | 68 | | Receiving a steroid at last consultation (%) | 51.7 | 51.3 | 51.9 | | Receiving a DMARD at last consultation (%) | 92.1 | 83.8 | 96.3 | | Number of DMARDs prescribed (%) | | | | | Zero | 7.9 | 16.3 | 3.8 | | One | 56.3 | 66.3 | 51.3 | | Two | 29.2 | 15.0 | 36.3 | | Three | 6.7 | 2.5 | 8.8 | | Type of DMARD (%) | | | | | Methotrexate | 79.2 | 75.0 | 81.3 | | Leflunomide | 29.6 | 13.8 | 37.5 | | Hydroxychloroquine | 13.8 | 8.8 | 16.3 | | Sulfasalazine | 9.2 | 5.0 | 11.3 | | Other (azathioprine, 6mercaptopurine, cyclosporine) | 2.9 | 1.3 | 3.8 |
|
|
